Compare PRLB & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRLB | OPK |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2012 | 1995 |
| Metric | PRLB | OPK |
|---|---|---|
| Price | $53.65 | $1.32 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $53.00 | $2.28 |
| AVG Volume (30 Days) | 124.7K | ★ 3.6M |
| Earning Date | 02-06-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | $518,384,000.00 | ★ $642,067,000.00 |
| Revenue This Year | $7.07 | N/A |
| Revenue Next Year | $4.87 | N/A |
| P/E Ratio | $90.17 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $29.59 | $1.11 |
| 52 Week High | $56.60 | $2.04 |
| Indicator | PRLB | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 51.19 | 49.22 |
| Support Level | $52.95 | $1.25 |
| Resistance Level | $56.60 | $1.43 |
| Average True Range (ATR) | 1.64 | 0.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 51.68 | 42.11 |
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.